Home » September / October 2023 » Shortage reporting & other issues that good data could solve right now
2023 | September / October 2023

Shortage reporting & other issues that good data could solve right now

by cyb2025
R. Munnik
EMA
EU IDMP
FDA
life sciences
regulatory data
supply chain

REMCO MUNNIK
Iperion – a Deloitte business, Barcelona, Spain

ABSTRACT

Waiting for regulators or software vendors to come up with the definitive rulebook for all future data reporting requirements is a bit like waiting for a tax office request to trigger accounts management. There will always be new compliance goals, but the real opportunity is about making good data work harder – something Life Sciences companies should be doing today. At Amplexor’s (now ArisGlobal) recent BE THE EXPERT 2023 global conference in June, Remco Munnik of Iperion – a Deloitte business, explored the broader process benefits and actionable insights that come within reach as soon as companies embrace the value of structured data in everything they do.

The fact that Life Sciences is now adopting and seeing value in structured data is a huge turning point for the industry, and this acceptance is becoming increasingly palpable. Once companies are able to see beyond the mandatory detail of the regulations that are helping to drive data-oriented process change, their opportunities for transformation of entire functions and their approaches to product tracking and management will broaden and multiply.

ABOUT THE AUTHOR

Remco Munnik is a Director at Iperion – a Deloitte business. As well as being a respected subject matter expert in RIM, eCTD, xEVMPD and ISO IDMP, Chair of Medicines for Europe Telematics group; and President of the IRISS Forum.

Latest issue

November /December 2025

View Issue

Archive

For an even more in-depth scientific analysis, consult the archive

Chemistry Today - Archive
Go to archive

Content from magazine

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.
View all content

Most popular

@2026 - All Right Reserved.

Login